title: The effects of DBcAMP on the expression of eNOS, iNOS and TGF-beta in rat heart tissue.
abstract: Dibutryl (DB) adenosine 3',5'-cyclic monophosphate (cAMP) is an important modulator of physiological functions. To determine the protective effects of DBcAMP on heart tissue, we evaluated changes in immunoreactivity of endothelial nitric oxide synthase (eNOS), inducible nitric oxide synthase (iNOS) and transforming growth factor-beta (TGF-beta) in left cervical vagotomized rats treated with DBcAMP. Male rats were divided into four groups. In Group 1, animals were subjected to a left cervical vagotomy. Group 2 received a 1 ml bolus injection of 15 ml/kg DBcAMP in addition to the left vagotomy. DBcAMP alone was given to Group 3 and Group 4 was the control group. For each animal, mean arterial pressure (MAP) and heart rate (HR) were measured. For indirect immunohistochemistry, anti-eNOS, anti-iNOS, and anti-TGF-beta primary antibodies were used. In Group 1, MAP and HR values decreased slightly. In Groups 2 and 3, DBcAMP induced a statistically significant drop in HR and MAP. In Group 1, strong eNOS, iNOS, and TGF-beta immunoreactivities were observed. Immunostaining intensities decreased in Groups 2 and 3. The results of the study reported here suggest that increased immunoreactivities of eNOS, iNOS, and TGF-beta might contribute to the effects on the heart tissue after left vagotomy and imply that DBcAMP acts on heart tissue via nitric oxide.
authors.affiliation: Department of Physiology, Celal Bayar University, Manisa, Turkey. aladag_nuran@yahoo.com
authors.forename: N
authors.initials: N
authors.lastname: Ekerbicer
authors.forename: S
authors.initials: S
authors.lastname: Inan
authors.forename: F
authors.initials: F
authors.lastname: Tarakci
authors.forename: T
authors.initials: T
authors.lastname: Zeren
mesh_terms: D000818:Animals; D003994:Bucladesine / Q000008:administration & dosage*; D004305:Dose-Response Relationship, Drug; D015870:Gene Expression / Q000187:drug effects; D008297:Male; D009206:Myocardium / Q000378:metabolism*; D052250:Nitric Oxide Synthase Type III / Q000378:metabolism*; D051381:Rats; D017207:Rats, Sprague-Dawley; D015398:Signal Transduction / Q000187:drug effects / Q000502:physiology*; D016212:Transforming Growth Factor beta / Q000378:metabolism*
chemical_list: D016212:Transforming Growth Factor beta; D003994:Bucladesine; D052250:Nitric Oxide Synthase Type III; C496316:Nos3 protein, rat